NCT04919564View on ClinicalTrials.gov

Low Dose Continuous Furosemide Effect on Cardiac Surgery Patients With Kidney Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 27, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

February 28, 2022

Conditions
Chronic Kidney DiseaseCardiac Disease
Interventions
DRUG

Furosemide in 0.9 % NaCl 100 Mg/100 mL (1 mg/mL)

Furosemide 2 mg/hour infusion for 12 hours since induction

DRUG

NaCl 0.9%

NaCl 0.9% 2 cc/hour for a period of 12 hours since anesthetic induction

Trial Locations (1)

11420

National Cardiovascular Center Harapan Kita Jakarta, Jakarta

All Listed Sponsors
lead

National Cardiovascular Center Harapan Kita Hospital Indonesia

OTHER